GN Store Nord: Dropping Coverage
We will discontinue analyst coverage of GN Store Nord on or about Oct. 14, 2026.
GN Store Nord AS GN
Bulls Say, Bears Say
Bulls
GN has strong relationships with large retailers, allowing it to generate high volume and benefit from scale. It is likely that these large retailers will continue to gain market share in the long term.
Bears
GN’s OTC expansion could destroy value if adoption is constrained by skepticism about self-fitting, while lower-priced Jabra devices could cannibalize midtier ReSound products.
Trading Information
- Previous Close Price
- DKK 108.25
- Day Range
- DKK 104.80–108.10
- 52-Week Range
- DKK 85.12–123.75
- Bid/Ask
- DKK 105.25 / DKK 105.50
- Shares Outstanding
- 145.61M
- Market Cap
- DKK 15.35B
- Volume/Avg
- 399,184 / 568,248
Key Statistics
- Price/Earnings (Normalized)
- 156.35
- Price/Sales
- 1.23
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
GN Store Nord is a Danish company offering medical and audio solutions. The group comprises three businesses: hearing (about 40% of sales), enterprise (40%), and gaming (20%). GN Hearing offers hearing aids and competes globally with Sonova, Demant, Starkey, and WS Audiology (formerly Sivantos and Widex). GN Enterprise provides headsets and speakerphones to the enterprise market, including contact centers and offices. GN recently acquired SteelSeries, a provider of gaming accessories such as headsets and keyboards, thereby forming the gaming division. The company has positioned itself as a major player in the Unified Communication-enabled headsets market. The firm's premium brands are Resound in hearing, Jabra in headsets, and SteelSeries in gaming.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 7,736
- Website
- https://www.gn.com
Competitors
Valuation
|
Metric
|
GN
|
DEMANT
|
SOON
|
|---|---|---|---|
Price/Earnings (Normalized) | 156.35 | 25.70 | 24.96 |
Price/Book Value | 1.54 | 5.89 | 5.69 |
Price/Sales | 1.23 | 2.69 | 4.14 |
Price/Cash Flow | 6.88 | 15.51 | 19.32 |
Price/Earnings
GN
DEMANT
SOON
Financial Strength
|
Metric
|
GN
|
DEMANT
|
SOON
|
|---|---|---|---|
Quick Ratio | 0.38 | 0.54 | 1.17 |
Current Ratio | 1.93 | 0.82 | 1.75 |
Interest Coverage | 0.18 | 6.70 | 23.14 |
Quick Ratio
GN
DEMANT
SOON
Profitability
|
Metric
|
GN
|
DEMANT
|
SOON
|
|---|---|---|---|
Return on Assets (Normalized) | −0.53% | 6.76% | 11.07% |
Return on Equity (Normalized) | −1.48% | 24.80% | 24.50% |
Return on Invested Capital (Normalized) | 0.50% | 9.75% | 16.97% |
Return on Assets
GN
DEMANT
SOON
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|?KDMnk | LOCK|!cqj | $167B | |||
| Medtronic PLC
MDT
| LOCK|vx$>g& | LOCK|P@?H# | $111B | |||
| Stryker Corp
SYK
| LOCK|<WS%?^y% | LOCK|?$ | $105B | |||
| Boston Scientific Corp
BSX
| LOCK|#xVs?w% | LOCK|>Z&s | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|Dw$!<#?z | LOCK|LpC@ | $49B | |||
| DexCom Inc
DXCM
| LOCK|PdFhlLHk | LOCK|$$#p@ | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|^>m!yS | LOCK|$& | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|vjl | LOCK|W$ | $23B | |||
| Steris PLC
STE
| LOCK|%JcBP? | LOCK|jvWN | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|#YZm!^J | LOCK|mZ? | $17B |
United States